» Articles » PMID: 8300209

Regulation of Actinobacillus Actinomycetemcomitans Leukotoxin Expression: Analysis of the Promoter Regions of Leukotoxic and Minimally Leukotoxic Strains

Overview
Journal Infect Immun
Date 1994 Feb 1
PMID 8300209
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

The leukotoxin of Actinobacillus actinomycetemcomitans has been implicated as a virulence determinant in various human infections and is encoded by a multigene operon consisting of four known genes, designated ltxC, ltxA, ltxB, and ltxD. The ltx operon appears to be present in all A. actinomycetemcomitans strains, but levels of toxin expression vary greatly among strains. Thus, to gain a better understanding of the expression and regulation of the ltx operon, we have analyzed the ltx promoters of a highly toxic (JP2) and a minimally toxic (652) strain of A. actinomycetemcomitans. The nucleotide sequence of the JP2 ltx promoter contains -10 and -35 elements situated 350 bases upstream of ltxC, and primer extension of JP2 RNA confirmed that they are functional in vivo. However, a second primer extension product of 40 bases was present, and analysis of a series of truncated JP2 promoters fused to lacZ suggested that the region immediately upstream of ltxC also promotes transcription in Escherichia coli. These results suggest that two promoters may direct ltx expression in JP2. In addition, a small open reading frame capable of encoding a peptide of 78 amino acids was identified upstream of ltxC. Northern blots showed that this open reading frame is transcribed as part of a 4.2-kb mRNA, a transcript not previously identified as being derived from the ltx operon. In contrast, strain 652 expresses low steady-state levels of ltx mRNA, and its intact ltx promoter was inefficient in transcribing lacZ in E. coli. The nucleotide sequence of the 652 promoter is similar to that of the JP2 promoter but contains a region of 530 bp that is not present in JP2. Of 15 additional strains of A. actinomycetemcomitans that were analyzed, 13 contained promoters resembling the 652 sequence and 2 possessed JP2-like promoters. Both strains possessing the JP2-like promoter expressed 10- to 20-fold-higher levels of leukotoxin than did the strains possessing promoters resembling the 652 promoter. These results suggest that high levels of leukotoxin expression may correlate with the presence of the JP2-like promoter.

Citing Articles

Prevalence of the oral pathogen and its FtxA toxin related to clinical parameters and presence of .

Razooqi Z, Khzam N, LHostis M, Belibasakis G, Johansson A, Oscarsson J Front Cell Infect Microbiol. 2025; 14:1501028.

PMID: 39911492 PMC: 11794325. DOI: 10.3389/fcimb.2024.1501028.


Occurrence of and Its JP2 Genotype in a Cohort of 220 Western Australians with Unstable Periodontitis.

Khzam N, Kujan O, Haubek D, Miranda L Microorganisms. 2024; 12(11).

PMID: 39597742 PMC: 11596974. DOI: 10.3390/microorganisms12112354.


Caspase-11 mediated inflammasome activation in macrophages by systemic infection of A. actinomycetemcomitans exacerbates arthritis.

Okano T, Ashida H, Komatsu N, Tsukasaki M, Iida T, Iwasawa M Int J Oral Sci. 2024; 16(1):54.

PMID: 39143049 PMC: 11324795. DOI: 10.1038/s41368-024-00315-x.


Leukotoxin A Production and Release by JP2 and Non-JP2 Genotype in Relation to Culture Conditions.

Kalfas S, Pour Z, Claesson R, Johansson A Pathogens. 2024; 13(7).

PMID: 39057796 PMC: 11279835. DOI: 10.3390/pathogens13070569.


Multivariate Analysis of Individual Bacterial Outer Membrane Vesicles Using Fluorescence Microscopy.

Singh A, Nice J, Wu M, Brown A, Wittenberg N Chem Biomed Imaging. 2024; 2(5):352-361.

PMID: 38817321 PMC: 11134603. DOI: 10.1021/cbmi.4c00014.


References
1.
Page M, KING E . Infection due to Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus. N Engl J Med. 1966; 275(4):181-8. DOI: 10.1056/NEJM196607282750403. View

2.
Lally E, Golub E, Kieba I, TAICHMAN N, Decker S, Berthold P . Structure and function of the B and D genes of the Actinobacillus actinomycetemcomitans leukotoxin complex. Microb Pathog. 1991; 11(2):111-21. DOI: 10.1016/0882-4010(91)90004-t. View

3.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

4.
TAICHMAN N, Dean R, Sanderson C . Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans. Infect Immun. 1980; 28(1):258-68. PMC: 550921. DOI: 10.1128/iai.28.1.258-268.1980. View

5.
Baehni P, Tsai C, McArthur W, HAMMOND B, Shenker B, TAICHMAN N . Leukotoxic activity in different strains of the bacterium Actinobacillus actinomycetemcomitans isolated from juvenile periodontitis in man. Arch Oral Biol. 1981; 26(8):671-6. DOI: 10.1016/0003-9969(81)90164-3. View